Peter Jordan

Dr. Peter Jordan

Department of Human Genetics, National Institute of Health Doutor Ricardo Jorge, Lisboa, Portugal
orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2000 in Cellular and Molecular Life Sciences
Verified
Journal Article
Closed access
PDF file
Peter JordanPeter Jordan
Peter Jordan
MCMaria Carmo-Fonseca
Maria Carmo-Fonseca

1 October 1995 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
TCT Carvalho
T Carvalho
JSJ S Seeler
J S Seeler
KOK Ohman
K Ohman
Peter JordanPeter Jordan
Peter Jordan
UPU Pettersson
U Pettersson
ADA Dejean
A Dejean
The PML protein was first identified as part of a fusion product with the retinoic acid receptor alpha (RAR alpha), resulting from the t(15;17) chromosomal translocation associated with acute promyelocytic leukemia (APL). It has been previously demonstrated that PML, which is tightly bound to the nuclear matrix, concentrates in discrete subnuclear compartments that are disorganized in APL cells due to the expression of the PML-RAR alpha hybrid. Here we report that adenovirus infection causes a drastic redistribution of PML from spherical nuclear bodies into fibrous structures. The product encoded by adenovirus E4-ORF3 is shown to be responsible for this reorganization and to colocalize with PML into these fibers. In addition, we demonstrate that E1A oncoproteins concentrate in the PML domains, both in infected and transiently transfected cells, and that this association requires the conserved amino acid motif (D)LXCXE, common to all viral oncoproteins that bind pRB or the related p107 and p130 proteins. The SV-40 large T antigen, another member of this oncoprotein family is also found in close association with the PML nuclear bodies. Taken together, the present data indicate that the subnuclear domains containing PML represent a preferential target for DNA tumor viruses, and therefore suggest a more general involvement of the PML nuclear bodies in oncogenic processes.

6 September 2001 in Oncogene
Verified
Journal Article
Closed access
FVFátima Veríssimo
Fátima Veríssimo
Peter JordanPeter Jordan
Peter Jordan

18 November 1999 in Oncogene
Verified
Journal Article
Closed access
Peter JordanPeter Jordan
Peter Jordan
RBRaquel Brazã£O
Raquel Brazã£O
MBMaria Guida Boavida
Maria Guida Boavida
CGChristian Gespach
Christian Gespach
Eric ChastreEric Chastre
Eric Chastre

1 October 2001 in Molecular Pathology
Verified
Journal Article
Open access
PDF file
LCLuka Clarke
Luka Clarke
CRC S Rebelo
C S Rebelo
JGJ Gonçalves
J Gonçalves
MBM G Boavida
M G Boavida
Peter JordanPeter Jordan
Peter Jordan
The polymerase chain reaction (PCR) is used universally for accurate exponential amplification of DNA. We describe a high error rate at mononucleotide and dinucleotide repeat sequence motifs. Subcloning of PCR products allowed sequence analysis of individual DNA molecules from the product pool and revealed that: (1) monothymidine repeats longer than 11 bp are amplified with decreasing accuracy, (2) repeats generally contract during PCR because of the loss of repeat units, (3) Taq and proofreading polymerase Pfu generate similar errors at mononucleotide and dinucleotide repeats, and (4) unlike the parent PCR product pool, individual clones containing a single repeat length produce no “shadow bands”. These data demonstrate that routine PCR amplification alters mononucleotide and dinucleotide repeat lengths. Such sequences are common components of genetic markers, disease genes, and intronic splicing motifs, and the amplification errors described here can be mistaken for polymorphisms or mutations.

15 April 1996 in Journal of Cell Biology
Verified
Journal Article
Open access
Peter JordanPeter Jordan
Peter Jordan
MMM Mannervik
M Mannervik
Laszlo ToraLaszlo Tora
Laszlo Tora
MCMaria Carmo-Fonseca
Maria Carmo-Fonseca
Here we show that the TATA-binding protein (TBP) is localized in the nucleoplasm and in the nucleolus of mammalian cells, consistent with its known involvement in transcription by RNA polymerase I, II, and III. In the nucleolus of actively growing cells, TBP colocalizes with upstream binding factor (UBF) and RNA polymerase I at the sites of rRNA transcription. During mitosis, when rRNA synthesis is down-regulated, TBP colocalizes with TBP-associated factors for RNA polymerase I (TAF(I)s), UBF, and RNA polymerase I on the chromosomal regions containing the rRNA genes. Treatment of cells with a low concentration of actinomycin D inhibits rRNA synthesis and causes a redistribution of the rRNA genes that become concentrated in clusters at the periphery of the nucleolus. A similar redistribution was observed for the major components of the rRNA transcription machinery (i.e., TBP, TAF(I)s, UBF, and RNA polymerase I), which still colocalized with each other. Furthermore, anti-TBP antibodies are shown to coimmunoprecipitate TBP and TAF(I)63 in extracts prepared from untreated and actinomycin D-treated cells. Collectively, the data indicate that in vivo TBP/promoter selectivity factor, UBF, and RNA polymerase I remain associated with both active and inactive rRNA genes.